Fig. 3 | Signal Transduction and Targeted Therapy

Fig. 3

From: An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma

Fig. 3

The performance of the immune signature in predicting outcome in ESCC with nCRT. Kaplan–Meier survival curves for OS based on the discriminant scores in training cohort (a), internal validation cohort (b), entire Beijing cohort (c), and the external validation cohort (d)

Back to article page